Global Stem Cell Therapy for Diabetes and Related Conditions Market Research Report 2023

Diabetes is the metabolic disorder that is associated with the glucose level in the blood. It is mainly divided into two types, insulin-dependent diabetes mellitus or juvenile onset (type 1) and non-insulin-dependent diabetes mellitus, or adult-onset diabetes (type 2).

The global Stem Cell Therapy for Diabetes and Related Conditions market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

NSI-566 is the stem cell therapy candidate under development by one of the key companies Neuralstem. The molecule is being developed for the treatment of individuals with diabetic neuropathy and is currently in the pre-clinical development stage. The mechanism of action of this stem cell therapy includes cell replacement that eventually leads to neurogenesis stimulation.

This report aims to provide a comprehensive presentation of the global market for Stem Cell Therapy for Diabetes and Related Conditions, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stem Cell Therapy for Diabetes and Related Conditions.

The Stem Cell Therapy for Diabetes and Related Conditions market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Stem Cell Therapy for Diabetes and Related Conditions market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Stem Cell Therapy for Diabetes and Related Conditions companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Stem Cell Therapy for Diabetes and Related Conditions Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Monotherapy

1.2.3 Combination Therapy

1.3 Market by Application

1.3.1 Global Stem Cell Therapy for Diabetes and Related Conditions Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Type 1 Diabetes Mellitus

1.3.3 Type 2 Diabetes Mellitus

1.3.4 Diabetic Foot Ulcer

1.3.5 Diabetic Nephropathy

1.3.6 Diabetic Neuropathy

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Stem Cell Therapy for Diabetes and Related Conditions Market Perspective (2018-2029)

2.2 Stem Cell Therapy for Diabetes and Related Conditions Growth Trends by Region

2.2.1 Global Stem Cell Therapy for Diabetes and Related Conditions Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Stem Cell Therapy for Diabetes and Related Conditions Historic Market Size by Region (2018-2023)

2.2.3 Stem Cell Therapy for Diabetes and Related Conditions Forecasted Market Size by Region (2024-2029)

2.3 Stem Cell Therapy for Diabetes and Related Conditions Market Dynamics

2.3.1 Stem Cell Therapy for Diabetes and Related Conditions Industry Trends

2.3.2 Stem Cell Therapy for Diabetes and Related Conditions Market Drivers

2.3.3 Stem Cell Therapy for Diabetes and Related Conditions Market Challenges

2.3.4 Stem Cell Therapy for Diabetes and Related Conditions Market Restraints

3.1 Global Top Stem Cell Therapy for Diabetes and Related Conditions Players by Revenue

3.1.1 Global Top Stem Cell Therapy for Diabetes and Related Conditions Players by Revenue (2018-2023)

3.1.2 Global Stem Cell Therapy for Diabetes and Related Conditions Revenue Market Share by Players (2018-2023)

3.2 Global Stem Cell Therapy for Diabetes and Related Conditions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Stem Cell Therapy for Diabetes and Related Conditions Revenue

3.4 Global Stem Cell Therapy for Diabetes and Related Conditions Market Concentration Ratio

3.4.1 Global Stem Cell Therapy for Diabetes and Related Conditions Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Stem Cell Therapy for Diabetes and Related Conditions Revenue in 2022

3.5 Stem Cell Therapy for Diabetes and Related Conditions Key Players Head office and Area Served

3.6 Key Players Stem Cell Therapy for Diabetes and Related Conditions Product Solution and Service

3.7 Date of Enter into Stem Cell Therapy for Diabetes and Related Conditions Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Stem Cell Therapy for Diabetes and Related Conditions Historic Market Size by Type (2018-2023)

4.2 Global Stem Cell Therapy for Diabetes and Related Conditions Forecasted Market Size by Type (2024-2029)

5.1 Global Stem Cell Therapy for Diabetes and Related Conditions Historic Market Size by Application (2018-2023)

5.2 Global Stem Cell Therapy for Diabetes and Related Conditions Forecasted Market Size by Application (2024-2029)

6.1 North America Stem Cell Therapy for Diabetes and Related Conditions Market Size (2018-2029)

6.2 North America Stem Cell Therapy for Diabetes and Related Conditions Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Stem Cell Therapy for Diabetes and Related Conditions Market Size by Country (2018-2023)

6.4 North America Stem Cell Therapy for Diabetes and Related Conditions Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Stem Cell Therapy for Diabetes and Related Conditions Market Size (2018-2029)

7.2 Europe Stem Cell Therapy for Diabetes and Related Conditions Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Stem Cell Therapy for Diabetes and Related Conditions Market Size by Country (2018-2023)

7.4 Europe Stem Cell Therapy for Diabetes and Related Conditions Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Stem Cell Therapy for Diabetes and Related Conditions Market Size (2018-2029)

8.2 Asia-Pacific Stem Cell Therapy for Diabetes and Related Conditions Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Stem Cell Therapy for Diabetes and Related Conditions Market Size by Region (2018-2023)

8.4 Asia-Pacific Stem Cell Therapy for Diabetes and Related Conditions Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Stem Cell Therapy for Diabetes and Related Conditions Market Size (2018-2029)

9.2 Latin America Stem Cell Therapy for Diabetes and Related Conditions Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Stem Cell Therapy for Diabetes and Related Conditions Market Size by Country (2018-2023)

9.4 Latin America Stem Cell Therapy for Diabetes and Related Conditions Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Stem Cell Therapy for Diabetes and Related Conditions Market Size (2018-2029)

10.2 Middle East & Africa Stem Cell Therapy for Diabetes and Related Conditions Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Stem Cell Therapy for Diabetes and Related Conditions Market Size by Country (2018-2023)

10.4 Middle East & Africa Stem Cell Therapy for Diabetes and Related Conditions Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Athersys

11.1.1 Athersys Company Detail

11.1.2 Athersys Business Overview

11.1.3 Athersys Stem Cell Therapy for Diabetes and Related Conditions Introduction

11.1.4 Athersys Revenue in Stem Cell Therapy for Diabetes and Related Conditions Business (2018-2023)

11.1.5 Athersys Recent Development

11.2 Mesoblast

11.2.1 Mesoblast Company Detail

11.2.2 Mesoblast Business Overview

11.2.3 Mesoblast Stem Cell Therapy for Diabetes and Related Conditions Introduction

11.2.4 Mesoblast Revenue in Stem Cell Therapy for Diabetes and Related Conditions Business (2018-2023)

11.2.5 Mesoblast Recent Development

11.3 Caladrius Biosciences

11.3.1 Caladrius Biosciences Company Detail

11.3.2 Caladrius Biosciences Business Overview

11.3.3 Caladrius Biosciences Stem Cell Therapy for Diabetes and Related Conditions Introduction

11.3.4 Caladrius Biosciences Revenue in Stem Cell Therapy for Diabetes and Related Conditions Business (2018-2023)

11.3.5 Caladrius Biosciences Recent Development

11.4 Sanofi

11.4.1 Sanofi Company Detail

11.4.2 Sanofi Business Overview

11.4.3 Sanofi Stem Cell Therapy for Diabetes and Related Conditions Introduction

11.4.4 Sanofi Revenue in Stem Cell Therapy for Diabetes and Related Conditions Business (2018-2023)

11.4.5 Sanofi Recent Development

11.5 Novo Nordisk

11.5.1 Novo Nordisk Company Detail

11.5.2 Novo Nordisk Business Overview

11.5.3 Novo Nordisk Stem Cell Therapy for Diabetes and Related Conditions Introduction

11.5.4 Novo Nordisk Revenue in Stem Cell Therapy for Diabetes and Related Conditions Business (2018-2023)

11.5.5 Novo Nordisk Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Stem Cell Therapy for Diabetes and Related Conditions Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Monotherapy

    Table 3. Key Players of Combination Therapy

    Table 4. Global Stem Cell Therapy for Diabetes and Related Conditions Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 5. Global Stem Cell Therapy for Diabetes and Related Conditions Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Stem Cell Therapy for Diabetes and Related Conditions Market Size by Region (2018-2023) & (US$ Million)

    Table 7. Global Stem Cell Therapy for Diabetes and Related Conditions Market Share by Region (2018-2023)

    Table 8. Global Stem Cell Therapy for Diabetes and Related Conditions Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 9. Global Stem Cell Therapy for Diabetes and Related Conditions Market Share by Region (2024-2029)

    Table 10. Stem Cell Therapy for Diabetes and Related Conditions Market Trends

    Table 11. Stem Cell Therapy for Diabetes and Related Conditions Market Drivers

    Table 12. Stem Cell Therapy for Diabetes and Related Conditions Market Challenges

    Table 13. Stem Cell Therapy for Diabetes and Related Conditions Market Restraints

    Table 14. Global Stem Cell Therapy for Diabetes and Related Conditions Revenue by Players (2018-2023) & (US$ Million)

    Table 15. Global Stem Cell Therapy for Diabetes and Related Conditions Market Share by Players (2018-2023)

    Table 16. Global Top Stem Cell Therapy for Diabetes and Related Conditions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cell Therapy for Diabetes and Related Conditions as of 2022)

    Table 17. Ranking of Global Top Stem Cell Therapy for Diabetes and Related Conditions Companies by Revenue (US$ Million) in 2022

    Table 18. Global 5 Largest Players Market Share by Stem Cell Therapy for Diabetes and Related Conditions Revenue (CR5 and HHI) & (2018-2023)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Stem Cell Therapy for Diabetes and Related Conditions Product Solution and Service

    Table 21. Date of Enter into Stem Cell Therapy for Diabetes and Related Conditions Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Stem Cell Therapy for Diabetes and Related Conditions Market Size by Type (2018-2023) & (US$ Million)

    Table 24. Global Stem Cell Therapy for Diabetes and Related Conditions Revenue Market Share by Type (2018-2023)

    Table 25. Global Stem Cell Therapy for Diabetes and Related Conditions Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 26. Global Stem Cell Therapy for Diabetes and Related Conditions Revenue Market Share by Type (2024-2029)

    Table 27. Global Stem Cell Therapy for Diabetes and Related Conditions Market Size by Application (2018-2023) & (US$ Million)

    Table 28. Global Stem Cell Therapy for Diabetes and Related Conditions Revenue Market Share by Application (2018-2023)

    Table 29. Global Stem Cell Therapy for Diabetes and Related Conditions Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 30. Global Stem Cell Therapy for Diabetes and Related Conditions Revenue Market Share by Application (2024-2029)

    Table 31. North America Stem Cell Therapy for Diabetes and Related Conditions Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 32. North America Stem Cell Therapy for Diabetes and Related Conditions Market Size by Country (2018-2023) & (US$ Million)

    Table 33. North America Stem Cell Therapy for Diabetes and Related Conditions Market Size by Country (2024-2029) & (US$ Million)

    Table 34. Europe Stem Cell Therapy for Diabetes and Related Conditions Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. Europe Stem Cell Therapy for Diabetes and Related Conditions Market Size by Country (2018-2023) & (US$ Million)

    Table 36. Europe Stem Cell Therapy for Diabetes and Related Conditions Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Asia-Pacific Stem Cell Therapy for Diabetes and Related Conditions Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Asia-Pacific Stem Cell Therapy for Diabetes and Related Conditions Market Size by Region (2018-2023) & (US$ Million)

    Table 39. Asia-Pacific Stem Cell Therapy for Diabetes and Related Conditions Market Size by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Stem Cell Therapy for Diabetes and Related Conditions Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Latin America Stem Cell Therapy for Diabetes and Related Conditions Market Size by Country (2018-2023) & (US$ Million)

    Table 42. Latin America Stem Cell Therapy for Diabetes and Related Conditions Market Size by Country (2024-2029) & (US$ Million)

    Table 43. Middle East & Africa Stem Cell Therapy for Diabetes and Related Conditions Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Middle East & Africa Stem Cell Therapy for Diabetes and Related Conditions Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Middle East & Africa Stem Cell Therapy for Diabetes and Related Conditions Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Athersys Company Detail

    Table 47. Athersys Business Overview

    Table 48. Athersys Stem Cell Therapy for Diabetes and Related Conditions Product

    Table 49. Athersys Revenue in Stem Cell Therapy for Diabetes and Related Conditions Business (2018-2023) & (US$ Million)

    Table 50. Athersys Recent Development

    Table 51. Mesoblast Company Detail

    Table 52. Mesoblast Business Overview

    Table 53. Mesoblast Stem Cell Therapy for Diabetes and Related Conditions Product

    Table 54. Mesoblast Revenue in Stem Cell Therapy for Diabetes and Related Conditions Business (2018-2023) & (US$ Million)

    Table 55. Mesoblast Recent Development

    Table 56. Caladrius Biosciences Company Detail

    Table 57. Caladrius Biosciences Business Overview

    Table 58. Caladrius Biosciences Stem Cell Therapy for Diabetes and Related Conditions Product

    Table 59. Caladrius Biosciences Revenue in Stem Cell Therapy for Diabetes and Related Conditions Business (2018-2023) & (US$ Million)

    Table 60. Caladrius Biosciences Recent Development

    Table 61. Sanofi Company Detail

    Table 62. Sanofi Business Overview

    Table 63. Sanofi Stem Cell Therapy for Diabetes and Related Conditions Product

    Table 64. Sanofi Revenue in Stem Cell Therapy for Diabetes and Related Conditions Business (2018-2023) & (US$ Million)

    Table 65. Sanofi Recent Development

    Table 66. Novo Nordisk Company Detail

    Table 67. Novo Nordisk Business Overview

    Table 68. Novo Nordisk Stem Cell Therapy for Diabetes and Related Conditions Product

    Table 69. Novo Nordisk Revenue in Stem Cell Therapy for Diabetes and Related Conditions Business (2018-2023) & (US$ Million)

    Table 70. Novo Nordisk Recent Development

    Table 71. Research Programs/Design for This Report

    Table 72. Key Data Information from Secondary Sources

    Table 73. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Stem Cell Therapy for Diabetes and Related Conditions Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Stem Cell Therapy for Diabetes and Related Conditions Market Share by Type: 2022 VS 2029

    Figure 3. Monotherapy Features

    Figure 4. Combination Therapy Features

    Figure 5. Global Stem Cell Therapy for Diabetes and Related Conditions Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 6. Global Stem Cell Therapy for Diabetes and Related Conditions Market Share by Application: 2022 VS 2029

    Figure 7. Type 1 Diabetes Mellitus Case Studies

    Figure 8. Type 2 Diabetes Mellitus Case Studies

    Figure 9. Diabetic Foot Ulcer Case Studies

    Figure 10. Diabetic Nephropathy Case Studies

    Figure 11. Diabetic Neuropathy Case Studies

    Figure 12. Stem Cell Therapy for Diabetes and Related Conditions Report Years Considered

    Figure 13. Global Stem Cell Therapy for Diabetes and Related Conditions Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 14. Global Stem Cell Therapy for Diabetes and Related Conditions Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 15. Global Stem Cell Therapy for Diabetes and Related Conditions Market Share by Region: 2022 VS 2029

    Figure 16. Global Stem Cell Therapy for Diabetes and Related Conditions Market Share by Players in 2022

    Figure 17. Global Top Stem Cell Therapy for Diabetes and Related Conditions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cell Therapy for Diabetes and Related Conditions as of 2022)

    Figure 18. The Top 10 and 5 Players Market Share by Stem Cell Therapy for Diabetes and Related Conditions Revenue in 2022

    Figure 19. North America Stem Cell Therapy for Diabetes and Related Conditions Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. North America Stem Cell Therapy for Diabetes and Related Conditions Market Share by Country (2018-2029)

    Figure 21. United States Stem Cell Therapy for Diabetes and Related Conditions Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Canada Stem Cell Therapy for Diabetes and Related Conditions Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Stem Cell Therapy for Diabetes and Related Conditions Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Stem Cell Therapy for Diabetes and Related Conditions Market Share by Country (2018-2029)

    Figure 25. Germany Stem Cell Therapy for Diabetes and Related Conditions Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. France Stem Cell Therapy for Diabetes and Related Conditions Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. U.K. Stem Cell Therapy for Diabetes and Related Conditions Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Italy Stem Cell Therapy for Diabetes and Related Conditions Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Russia Stem Cell Therapy for Diabetes and Related Conditions Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Nordic Countries Stem Cell Therapy for Diabetes and Related Conditions Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Stem Cell Therapy for Diabetes and Related Conditions Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Stem Cell Therapy for Diabetes and Related Conditions Market Share by Region (2018-2029)

    Figure 33. China Stem Cell Therapy for Diabetes and Related Conditions Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Japan Stem Cell Therapy for Diabetes and Related Conditions Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. South Korea Stem Cell Therapy for Diabetes and Related Conditions Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Southeast Asia Stem Cell Therapy for Diabetes and Related Conditions Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. India Stem Cell Therapy for Diabetes and Related Conditions Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Australia Stem Cell Therapy for Diabetes and Related Conditions Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Stem Cell Therapy for Diabetes and Related Conditions Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Stem Cell Therapy for Diabetes and Related Conditions Market Share by Country (2018-2029)

    Figure 41. Mexico Stem Cell Therapy for Diabetes and Related Conditions Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Brazil Stem Cell Therapy for Diabetes and Related Conditions Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Stem Cell Therapy for Diabetes and Related Conditions Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Stem Cell Therapy for Diabetes and Related Conditions Market Share by Country (2018-2029)

    Figure 45. Turkey Stem Cell Therapy for Diabetes and Related Conditions Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Saudi Arabia Stem Cell Therapy for Diabetes and Related Conditions Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Athersys Revenue Growth Rate in Stem Cell Therapy for Diabetes and Related Conditions Business (2018-2023)

    Figure 48. Mesoblast Revenue Growth Rate in Stem Cell Therapy for Diabetes and Related Conditions Business (2018-2023)

    Figure 49. Caladrius Biosciences Revenue Growth Rate in Stem Cell Therapy for Diabetes and Related Conditions Business (2018-2023)

    Figure 50. Sanofi Revenue Growth Rate in Stem Cell Therapy for Diabetes and Related Conditions Business (2018-2023)

    Figure 51. Novo Nordisk Revenue Growth Rate in Stem Cell Therapy for Diabetes and Related Conditions Business (2018-2023)

    Figure 52. Bottom-up and Top-down Approaches for This Report

    Figure 53. Data Triangulation

    Figure 54. Key Executives Interviewed